Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease–associated cachexia is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 56 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH NCI
Grant: CA184324,1R43CA150703,2R44CA150703,2R44CA210763
NCI NIH HHS
Grant: R43 CA150703
NCI NIH HHS
Grant: R44 CA150703
NCI NIH HHS
Grant: R44 CA210763
NCI NIH HHS
Grant: R01 CA184324
National Institutes of Health
Grant: 1R44CA210763-01
Development of a Cancer Cachexia Therapeutic
National Institutes of Health
Grant: 3R01CA184324-02S1
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
National Institutes of Health
Grant: 1R43CA150703-01
Melanocortin Ligands in Disease Cachexia
FWCI
1.76
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals